Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
21.80
-0.67 (-2.98%)
At close: Oct 8, 2025, 4:00 PM EDT
21.88
+0.08 (0.37%)
After-hours: Oct 8, 2025, 7:31 PM EDT

Oscar Health Statistics

Total Valuation

Oscar Health has a market cap or net worth of $5.63 billion. The enterprise value is $3.32 billion.

Market Cap5.63B
Enterprise Value 3.32B

Important Dates

The next confirmed earnings date is Thursday, November 6, 2025, before market open.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Oscar Health has 258.24 million shares outstanding. The number of shares has decreased by -4.81% in one year.

Current Share Class 222.73M
Shares Outstanding 258.24M
Shares Change (YoY) -4.81%
Shares Change (QoQ) -16.48%
Owned by Insiders (%) 3.47%
Owned by Institutions (%) 63.33%
Float 210.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.52
Forward PS 0.46
PB Ratio 5.01
P/TBV Ratio 4.80
P/FCF Ratio 4.63
P/OCF Ratio 4.51
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.31
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 2.76

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.31.

Current Ratio 0.89
Quick Ratio 0.84
Debt / Equity 0.31
Debt / EBITDA n/a
Debt / FCF 0.30
Interest Coverage -5.47

Financial Efficiency

Return on equity (ROE) is -13.96% and return on invested capital (ROIC) is -5.35%.

Return on Equity (ROE) -13.96%
Return on Assets (ROA) -1.42%
Return on Invested Capital (ROIC) -5.35%
Return on Capital Employed (ROCE) -8.53%
Revenue Per Employee $4.47M
Profits Per Employee -$67,180
Employee Count2,400
Asset Turnover 1.88
Inventory Turnover n/a

Taxes

In the past 12 months, Oscar Health has paid $9.33 million in taxes.

Income Tax 9.33M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +17.97% in the last 52 weeks. The beta is 1.89, so Oscar Health's price volatility has been higher than the market average.

Beta (5Y) 1.89
52-Week Price Change +17.97%
50-Day Moving Average 17.49
200-Day Moving Average 15.52
Relative Strength Index (RSI) 67.01
Average Volume (20 Days) 18,501,094

Short Selling Information

The latest short interest is 34.58 million, so 13.39% of the outstanding shares have been sold short.

Short Interest 34.58M
Short Previous Month 57.68M
Short % of Shares Out 13.39%
Short % of Float 16.46%
Short Ratio (days to cover) 1.96

Income Statement

In the last 12 months, Oscar Health had revenue of $10.73 billion and -$161.23 million in losses. Loss per share was -$0.69.

Revenue10.73B
Gross Profit 1.84B
Operating Income -129.47M
Pretax Income -151.33M
Net Income -161.23M
EBITDA -99.03M
EBIT -129.47M
Loss Per Share -$0.69
Full Income Statement

Balance Sheet

The company has $3.54 billion in cash and $357.22 million in debt, giving a net cash position of $2.24 billion or $8.68 per share.

Cash & Cash Equivalents 3.54B
Total Debt 357.22M
Net Cash 2.24B
Net Cash Per Share $8.68
Equity (Book Value) 1.16B
Book Value Per Share 4.49
Working Capital -552.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.23 billion and capital expenditures -$32.69 million, giving a free cash flow of $1.20 billion.

Operating Cash Flow 1.23B
Capital Expenditures -32.69M
Free Cash Flow 1.20B
FCF Per Share $4.65
Full Cash Flow Statement

Margins

Gross margin is 17.20%, with operating and profit margins of -1.21% and -1.50%.

Gross Margin 17.20%
Operating Margin -1.21%
Pretax Margin -1.41%
Profit Margin -1.50%
EBITDA Margin -0.92%
EBIT Margin -1.21%
FCF Margin 11.20%

Dividends & Yields

Oscar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.81%
Shareholder Yield 4.81%
Earnings Yield -2.90%
FCF Yield 21.60%
Dividend Details

Analyst Forecast

The average price target for Oscar Health is $12.64, which is -42.02% lower than the current price. The consensus rating is "Sell".

Price Target $12.64
Price Target Difference -42.02%
Analyst Consensus Sell
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3